The Independent’s journalism is supported by our readers. When you purchase through links on our site, we may earn commission.

Medical marijuana could put an end to my constant pain, but I can't even try it without breaking the law

I don't understand how the NHS can be so behind countries like America, as legalisation would benefit so many and save millions

Mira Bar Hillel
Wednesday 11 March 2015 16:15
Comments

Three American senators are today introducing a bill which will legalise medical marijuana under federal law across the US. The bill will not compel individual states to allow medical use of the drug but will ensure that those which do – 23 so far – will not be overridden by federal law enforcement.

The proposal is called the “Compassionate Access, Research Expansion and Respect States (CARERS) Act” and it will also seek to recognise the medical benefits of cannabis in its drug classification.

The initiative, coming as it does from country not noted for being “soft on drugs”, has left me feeling betrayed by Britain and our much-vaunted NHS.

I suffer from a condition known as “peripheral neuropathy”. It is the irreversible degeneration of the nerve endings in the extremities, in my case the soles of the feet, which feel as if they are on fire all the time.

There is no cure and no pain relief is effective. I can walk, but slowly and not more than 50 yards or so. My newly acquired Blue Badge allows parking close enough to various destinations to make it, but a wheelchair is my constant companion. Worse still, the 24/7 pain is exhausting and makes it very hard to fall asleep, as it seems to hurt most as I am trying to doze off.

I have been seeing a leading neurological consultant and tried conventional medications which managed to dull my senses without alleviating the pain. He concluded that the best I could hope for was for the nerve endings to die, ending the pain. My feet would then be completely numb, which would still make walking awkward, but I would at least be able to sleep. So far there is no sign of this happening.

Following a trip abroad, I suggested that cannabis might offer me relief. He jocularly suggested a quick visit to Amsterdam and more seriously that as cannabis affects the nervous system – and is established as being effective for MS sufferers – it could help me. But he could only give me a cannabinoid compound, Sativex, made by pharma giant Bayer, which I could only obtain on private prescription. It cost me £500 to discover that this particular formulation was not what I required.

However, the expert agreed that other forms could be more effective – and vastly cheaper – but none are now legal, so I cannot even try them without breaking the law.

The legalisation of medical marijuana is 23 states in the US has created a mini-boom in specialist dispensaries where various types and combinations are offered for different conditions, designed to be smoked (I don’t smoke and don’t wish to) but also taken as oils and incorporated into food, especially cakes.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in